Fig. 1
From: NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth
Expression of NAP1L1 in breast cancer. A Upregulated NAP1L1 protein expression in breast cancer in CPTAC (http://ualcan.path.uab.edu/) (Z-values represent standard deviations from the median across samples for the given cancer type. The Log2 spectral count ratios obtained from CPTAC were first normalized within each sample profile and then normalized across samples). B Upregulated NAP1L1 protein levels were measured via immunohistochemical staining in breast cancer compared to paracarcinoma tissues (97 breast cancer tissue samples and 10 paracarcinoma tissue samples,100 × visual field scale bar: 200 μm 200 × visual field scale bar: 100 μm). C NAP1L1 expression performed in TMA (97 breast cancer tissue samples and 10 paracarcinoma tissue samples, scale bar: 50 μm). D Kaplan–Meier survival analysis for the overall survival in TMA performed NAP1L1 expression (25 high expression of NAP1L1 samples and 72 low expression of NAP1L1 samples)